UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period ended Commission File Number: 001-35477 (I.R.S. Employer Identification No.) Greer, South Carolina 29651 (Address of principal executive offices) (Zip Code) (864) 448-700 ...

Exhibit 99.1 TTEC Announces Third Quarter 2025 Financial Results AUSTIN, Texas, November 6, 2025 – TTEC Holdings, Inc. (NASDAQ:TTEC), a leading global CX (customer experience) technology and services innovator for AI-enabled CX with solutions from TTEC Engage and TTEC Digital, announced today financial results for the third quarter ended September 30, 2025. "Our third quarter 2025 financial performance delivered to plan as we continue to balance operational excellence with investments in innovation and grow ...

Revenue and Profit - Revenue decreased by $8.99 million, or 22.8%, from $39.34 million in Q3 2024 to $30.35 million in Q3 2025[141] - Gross profit decreased by $2.53 million, or 32.9%, from $7.67 million in Q3 2024 to $5.15 million in Q3 2025, with gross margin declining from 19.5% to 17.0%[144] - Net loss for Q3 2025 was $3.26 million, compared to a net loss of $5.60 million in Q3 2024, representing a reduction in loss[139] - Net loss decreased from $5,595,016 or $(0.10) per share in Q3 2024 to $3,258,863 or $(0.06) per share in Q3 2025, a reduction of $2,336,153[155] Expenses - Operating expenses decreased by $5.10 million, or 39.4%, from $12.94 million in Q3 2024 to $7.84 million in Q3 2025[145] - Sales and marketing expenses decreased by $1.43 million, or 47.7%, from $2.99 million in Q3 2024 to $1.56 million in Q3 2025[146] Assets and Liabilities - Current assets increased by 3.0% from $72,908,000 on June 30, 2025 to $75,128,000 on September 30, 2025, while current liabilities decreased by 9.3% from $72,540,000 to $65,813,000[157] - Working capital surged by 2,431.3% from $368,000 to $9,315,000 between June 30, 2025 and September 30, 2025[157] - Total lease liabilities as of September 30, 2025 amounted to $4,634,267, with future lease payments totaling $5,085,404[168] - As of September 30, 2025, the company had a borrowing balance of $1,665,435, with maturities scheduled for $1,146,766 in the next year[168] - Contract liabilities decreased from $4,861,250 on June 30, 2025 to $2,962,299 on September 30, 2025, indicating a reduction in advance deposits received[165] Cash Flow - Net cash used in operating activities for Q3 2025 was $(1,184,000), a decrease of $4,794,000 compared to $3,610,000 in Q3 2024[159] - Cash flow from investing activities was $(140,000) in Q3 2025, down from $(925,000) in Q3 2024, reflecting a decrease of $785,000[161] Other Financial Metrics - The allowance for credit losses was $17.3 million as of September 30, 2025, down from $18.0 million as of June 30, 2025[135] - Interest income increased to $95,472 in Q3 2025 from $86 in Q3 2024, primarily due to late fees charged to customers[150] - Income taxes increased by $29,316, or 6.4%, from $456,753 in Q3 2024 to $486,069 in Q3 2025, despite a consolidated net loss[154] Capital and Investments - The company raised approximately $10.6 million in March 2024 through a public offering priced at $6.00 per share, aimed at funding operations and R&D[132] - The company recorded an unpaid $5.8 million consideration in accrued liabilities for a committed investment of $9 million into a joint venture named IKE Tech LLC[168] Regulatory Status - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to take advantage of reduced reporting requirements[172] Geographic Revenue - Revenue from Europe increased to 68.2% of total revenue in Q3 2025, up from 55.8% in Q3 2024[140]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) incorporation or organization) Indian ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________ Commission File Number 000-31311 PDF SOLUTIONS, INC. (Exact name of Registrant as Specified in its Charter) Delaware 25-1701361 (St ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2025 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number 001-09279 ONE LIBERTY PROPERTIES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. employer incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-36869 PJT Partners Inc. (Exact name of registrant as specified in its charter) Delaware 36-4797143 (State or other jurisdic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to x Commission file number 000-19291 CORVEL CORPORATION (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporat ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Commission file number: 001-37846 QUOIN PHARMACEUTICALS LTD. (Exact name of registrant as specified in its chart ...

Exhibit 99.1 Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics - - Completed $60.3 million oversubscribed private placement led by Samsara BioCapital with participation from RA Capital Management, Anomaly, Special Situations Funds, and Invus – – Appointed Abraham Bassan and Vasudev Bailey, Ph.D. to the Board of Directors – - Cash runway expected to extend ...